Human Function and Whole Person Health Financing:A Continuity-of-Care and Payment Framework Linking Prevention and Treatment
Background Clinical services and health financing already use disease classifications, functioning information and coordinated care. A further question is how an account of the same person's bodily operation can support justified action across prevention, treatment, rehabilitation and nursing care, and how that work should be purchased. Objective To specify this application of the Unified Ontology of Human Function (UOHF) and Human Function World Model (HFWM), examine its overlap with existing approaches, and identify conditions under which it could improve outcomes and efficiency. Methods We combined analysis of the antecedent framework, a targeted audit of primary research and official policies, a constructed clinical episode, and deterministic economic calculations with independent exact-arithmetic checks. Results The proposed mechanism connects native medical and physiological models with demand, capacity, actual engagement, evidence, conditional change and professional action. Clinical justification, feasibility of the next setting and financing responsibility have distinct criteria. Semantic and model support, service delivery and payment incentives are also distinct interventions; evidence for one cannot establish the effect of another. Existing clinical studies supply both beneficial and null examples, and lower acute-care use does not guarantee expenditure savings. Executed hypothetical counterexamples show that identical mean risk, mean service uptake and total programme expenditure can yield opposite saving signs when uptake differs by risk group. Harmful effects and cross-account cost shifts can further reverse an apparent benefit. Conclusion Human function offers a scientific foundation for making warranted preventive, therapeutic and transitional work explicit and evaluable. This financing application establishes a set of relations, decision conditions and reproducible counterexamples, not an observed HFWM clinical or financial effect. Its incremental value requires comparison with mature care, equivalent representations and explicitly specified payment arrangements.
Authors
- LEI CHE (ORCID: https://orcid.org/0009-0001-8143-1675)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2026-11-18
- DOI
- https://doi.org/10.5281/zenodo.24354538
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- preprint